| Silver staining of proteins in polyacrylamide gels W Wray, T Boulikas, VP Wray, R Hancock Analytical biochemistry 118 (1), 197-203, 1981 | 3945 | 1981 |
| Cisplatin and platinum drugs at the molecular level T Boulikas, M Vougiouka Oncology reports 10 (6), 1663-1682, 2003 | 1102 | 2003 |
| Nuclear localization signals (NLS). T Boulikas Critical reviews in eukaryotic gene expression 3 (3), 193-227, 1993 | 438 | 1993 |
| Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs T Boulikas, M Vougiouka Oncology reports 11 (3), 559-595, 2004 | 378 | 2004 |
| Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin T Boulikas Expert opinion on investigational drugs 18 (8), 1197-1218, 2009 | 353 | 2009 |
| Chromatin domains and prediction of MAR sequences T Boulikas International review of cytology 162, 279-388, 1996 | 346 | 1996 |
| Putative nuclear localization signals (NLS) in protein transcription factors T Boulikas Journal of cellular biochemistry 55 (1), 32-58, 1994 | 300 | 1994 |
| Designing platinum compounds in cancer: structures and mechanisms T Boulikas, A Pantos, E Bellis, P Christofis Cancer Ther 5, 537-583, 2007 | 287 | 2007 |
| Nature of DNA sequences at the attachment regions of genes to the nuclear matrix T Boulikas Journal of cellular biochemistry 52 (1), 14-22, 1993 | 258 | 1993 |
| Lipoplatin formulation review article GP Stathopoulos, T Boulikas Journal of drug delivery 2012, 2012 | 249 | 2012 |
| Points of contact between histone H1 and the histone octamer. T Boulikas, JM Wiseman, WT Garrard Proceedings of the National Academy of Sciences 77 (1), 127-131, 1980 | 215 | 1980 |
| Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 … H Ren, T Boulikas, A Söling, PC Warnke, NG Rainov Journal of neuro-oncology 64, 147-154, 2003 | 198 | 2003 |
| Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study GP Stathopoulos, T Boulikas, M Vougiouka, G Deliconstantinos, ... Oncology reports 13 (4), 589-595, 2005 | 196 | 2005 |
| Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts T Boulikas Oncology reports 12 (1), 3-12, 2004 | 189 | 2004 |
| Systemic Lipoplatin infusion results in preferential tumor uptake in human studies T Boulikas, GP Stathopoulos, N Volakakis, M Vougiouka Anticancer Research 25 (4), 3031-3039, 2005 | 182 | 2005 |
| Functional organization in the nucleus R Hacock, T Boulikas International review of cytology 79, 165-214, 1982 | 172 | 1982 |
| Relation between carcinogenesis, chromatin structure and poly (ADP-ribosylation) T Boulikas Anticancer research 11 (2), 489-527, 1991 | 170 | 1991 |
| Viral and non-viral vectors in gene therapy: technology development and clinical trials K Lundstrom, T Boulikas Technology in cancer research & treatment 2 (5), 471-485, 2003 | 167 | 2003 |
| Phosphorylation of transcription factors and control of the cell cycle. T Boulikas Critical reviews in eukaryotic gene expression 5 (1), 1-77, 1995 | 164 | 1995 |
| Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes T Boulikas US Patent 6,511,676, 2003 | 142 | 2003 |
